Careers  |  Sign In  |  Register

FDA Approves First Test for Cervical Cancer as an Alternative to a Pap Smear

Bloomberg News reports that “Roche Holding AG (ROG) won U.S. approval for the first test to screen for cervical cancer that will serve as an alternative to a Pap smear.” The test, called cobas HPV test, can detect DNA from 14 human papillomavirus types, but “primarily detects two types of HPV responsible for about 70 percent of cervical cancers, which if found should be followed by a procedure known as a colposcopy that may include a cervical biopsy.” Some patient and consumer groups believe the test should not replace Pap smears because “there isn’t enough data comparing HPV screening with the combination method” that includes a Pap smear and HPV screening.

Read it in Bloomberg News.